Literature DB >> 31875952

Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people.

Nimesh A Jayasuriya1,2, Alisa D Kjaergaard1,3, Kasper M Pedersen4,5,6, Anders L Sørensen4,5, Marie Bak5, Morten K Larsen5,7, Børge G Nordestgaard4,8, Stig E Bojesen4,8, Yunus Çolak4,8, Vibe Skov5, Lasse Kjaer5, Janne S Tolstrup9,10, Hans C Hasselbalch4,5, Christina Ellervik1,4,11,12.   

Abstract

Meta-analyses and Mendelian randomization (MR) may clarify the associations of smoking, blood cells and myeloproliferative neoplasms (MPN). We investigated the association of smoking with blood cells in the Danish General Suburban Population Study (GESUS, n = 11 083), by meta-analyses (including GESUS) of 92 studies (n = 531 741) and MR of smoking variant CHRNA3 (rs1051730[A]) in UK Biobank, and with MPN in a meta-analysis of six studies (n (total/cases):1 425 529/2187), totalling 2 307 745 participants. In the meta-analysis the random-effects standardized mean difference (SMD) in current smokers versus non-smokers was 0·82 (0·75-0·89, P = 2·0 * 10-108 ) for leukocytes, 0·09 (-0·02 to 0·21, P = 0·12) for erythrocytes, 0·53 (0·42-0·64, P = 8·0 * 10-22 ) for haematocrit, 0·42 (0·34-0·51, P = 7·1 * 10-21 ) for haemoglobin, 0·19 (0·08-0·31, P = 1·2 * 10-3 ) for mean corpuscular haemoglobin (MCH), 0·29 (0·19-0·39, P = 1·6 * 10-8 ) for mean corpuscular volume (MCV), and 0·04 (-0·04 to 0·13, P = 0·34) for platelets with trends for ever/ex-/current smokers, light/heavy smokers and female/male smokers. Analyses presented high heterogeneity but low publication bias. Per allele in CHRNA3, cigarettes per day in current smokers was associated with increased blood cell counts (leukocytes, neutrophils), MCH, red cell distribution width (RDW) and MCV. The pooled fixed-effects odds ratio for MPN was 1·44 [95% confidence interval (CI): 1·33-1·56; P = 1·8 * 10-19 ; I2  = 0%] in current smokers, 1·29 (1·15-1·44; P = 8·0 * 10-6 ; I2  = 0%) in ex-smokers, 1·49 (1·26-1·77; P = 4·4 * 10-6 ; I2  = 0%) in light smokers and 2·04 (1·74-2·39, P = 2·3 * 10-18 ; I2  = 51%) in heavy smokers compared with non-smokers. Smoking is observationally and genetically associated with increased leukocyte counts and red blood cell indices (MCH, MCV, RDW) and observationally with risk of MPN in current and ex-smokers versus non/never-smokers.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  blood cells; erythrocytes; essential thrombocythaemia; haematocrit; haemoglobin; leukocytes; meta-analysis; myelofibrosis; myeloproliferative neoplasms; polycythaemia vera; thrombocytes; tobacco smoking

Year:  2019        PMID: 31875952     DOI: 10.1111/bjh.16321

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  Applied genomics in MPN presentation.

Authors:  Alison R Moliterno; Hannah Kaizer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

2.  Smoking Impairs Hematoma Formation and Dysregulates Angiogenesis as the First Steps of Fracture Healing.

Authors:  Helen Rinderknecht; Andreas K Nussler; Konrad Steinestel; Tina Histing; Sabrina Ehnert
Journal:  Bioengineering (Basel)       Date:  2022-04-24

3.  An analysis of the 28-day mortality risk factors in acute respiratory distress syndrome patients and the establishment of prediction models.

Authors:  Hui Chen; Qiong Liu; Lifeng Wang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 4.  Clinical insights into the origins of thrombosis in myeloproliferative neoplasms.

Authors:  Alison R Moliterno; Yelena Z Ginzburg; Ronald Hoffman
Journal:  Blood       Date:  2021-03-04       Impact factor: 22.113

Review 5.  Impact of Host, Lifestyle and Environmental Factors in the Pathogenesis of MPN.

Authors:  Gajalakshmi Ramanathan; Brianna M Hoover; Angela G Fleischman
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.575

Review 6.  Is there a gender effect in polycythemia vera?

Authors:  Francesca Palandri; Barbara Mora; Naseema Gangat; Lucia Catani
Journal:  Ann Hematol       Date:  2020-10-02       Impact factor: 3.673

7.  Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care.

Authors:  Sarah F Christensen; Robyn M Scherber; Gina L Mazza; Amylou C Dueck; Nana Brochmann; Christen L Andersen; Hans C Hasselbalch; Ruben A Mesa; Holly L Geyer
Journal:  BMC Cancer       Date:  2021-06-10       Impact factor: 4.430

8.  Systematic review of Mendelian randomization studies on risk of cancer.

Authors:  Georgios Markozannes; Afroditi Kanellopoulou; Olympia Dimopoulou; Dimitrios Kosmidis; Xiaomeng Zhang; Lijuan Wang; Evropi Theodoratou; Dipender Gill; Stephen Burgess; Konstantinos K Tsilidis
Journal:  BMC Med       Date:  2022-02-02       Impact factor: 11.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.